Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, As Represented By”
2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7795208
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
granted -
US 7794714
Newcastle disease virus monoclonal antibodies
granted -
US 7794998
Primate T-lymphotropic viruses
granted -
US 7790473
Biofunctionalized quantum dots for biological imaging
granted -
US 7790764
Biologically active macrolides, compositions, and uses thereof
granted -
US 7790735
Methanocarba cycloalkyl nucleoside analogues
granted -
US 7785565
Metal chelators and methods of their use
granted -
US 7781445
Synthesis of indenoisoquinoliniums and methods of use
granted -
US 7777019
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted -
US 7776883
Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)
granted -
US 7776607
Mammalian selenoprotein differentially expressed in tumor cells
granted -
US 7776337
Bacteriocins and novel bacterial strains
granted -
US 7771715
Recombinant vector expressing multiple costimulatory molecules and uses thereof
granted -
US 7771729
Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors
granted -
US 7767645
SH2 domain binding inhibitors
granted -
US 7763451
Methods for preparing Bacillus anthracis protective antigen for use in vaccines
granted -
US 7763719
Variants of humanized anti-carcinoma MAb CC49
granted -
US 7763586
Melanoma antigens and their use in diagnostic and therapeutic methods
granted -
US 7759330
21-substituted progesterone derivatives as new antiprogestational agents
granted -
US 7758876
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
granted -
US 7758855
DNA promoters and anthrax vaccines
granted -
US 7754227
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
granted -
US 7754420
Methods of using cyanovirins to inhibit viral infection
granted -
US 7754676
Defensin-antigen fusion proteins
granted